memsorb for Anesthesia

Queen Elizabeth II HSC, Halifax Infirmary Site, Halifax, Canada
Anesthesiamemsorb - Device
Eligibility
Any Age
All Sexes

Study Summary

This trialshows the drawbacks of chemical CO2 absorbers: they create harmful compounds, increasing cost and environmental impact, & require daily disposal of special waste. Sustainable management of anesthesia is a growing concern.

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Similar Trials

1
Continuous Adductor Canal Catheter (ACC)
1
Gutta Percha
2
HSK3486

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: during preoperative assessment

Single collected measurement not more than 60 min after extubation
pH measurement
Up to 12h
Anaesthetic agent
Arterial blood CO2 partial pressure
Arterial blood oxygen saturation
Blood pressure
End Tidal CO2
Fractional concentration of inspired CO2
Fractional concentration of inspired O2
Fresh gas flow
Heart rate
Length of surgery
Patient temperature
Relaxation status
Tidal volume
Ventilation frequency
Ventilation pressure
during preoperative assessment
Lung disease
Patient age
Patient height
Patient medications
Patient weight

Trial Safety

Phase-Based Safety

1 of 3

Similar Trials

1
Continuous Adductor Canal Catheter (ACC)
2
Gutta Percha
3
HSK3486

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Control
1 of 2
memsorb
1 of 2

Active Control

Experimental Treatment

450 Total Participants · 2 Treatment Groups

Primary Treatment: memsorb · No Placebo Group · N/A

memsorb
Device
Experimental Group · 1 Intervention: memsorb · Intervention Types: Device
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
memsorb
2014
N/A
~20

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: during preoperative assessment

Who is running the clinical trial?

DMF Medical IncorporatedLead Sponsor
2 Previous Clinical Trials
70 Total Patients Enrolled
Orlando Hung, MDPrincipal InvestigatorNova Scotia Health Authority

Eligibility Criteria

Age Any Age · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Frequently Asked Questions

What is the current size of participation for this investigation?

"Affirmative. Based on the clinical trial information hosted by clinicaltrials.gov, this medical study is actively enlisting participants. The research project was first shared online on January 1st 2017 and had its most recent update on November 18th 2022. 450 individuals need to be recruited from a single centre for the experiment to move forward as planned." - Anonymous Online Contributor

Unverified Answer

Is this research project currently seeking volunteer participants?

"Affirmative. Clinicaltrials.gov points to this research investigation actively seeking patients, which was initially publicized on January 1st 2017. The most recent update is from November 18th 2022 and 450 individuals are needed from a single clinical centre." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top